Venus Concept Inc Stock Price, News & Analysis

Venus Concept (NASDAQ: VERO) reported a 56% increase in total revenue for Q1 2021, reaching $22.6 million compared to $14.5 million in Q1 2020. The company's gross margin improved to 67.4% from 64.0%, while the GAAP operating loss significantly decreased to $6.8 million from $43.6 million year-over-year. Adjusted EBITDA loss decreased 63% to $5.0 million. The company revised its 2021 revenue guidance to $100 million to $105 million, an anticipated growth of 28% to 35%.

Venus Concept (NASDAQ: VERO) announced its financial results for Q1 fiscal year 2021 will be released on May 17, 2021, after market close. A conference call is scheduled for the same day at 5:00 PM ET to discuss these results, with participation details provided for both domestic and international callers. The call will also be available via a live webcast and archived for later access. Venus Concept is known for its innovative medical aesthetic technologies, operating in over 60 countries with a subscription-based sales model.

Venus Concept (NASDAQ: VERO) reported Q4 2020 revenue of $25.8 million, down 19% YoY from $31.9 million, impacted by COVID-19. However, it marked a 25% increase from Q3 2020's $20.7 million. The operating loss decreased by 42% YoY to $10.3 million, with a net loss of $15.0 million, improving from $22.7 million in Q4 2019. Adjusted EBITDA loss was $2.4 million, compared to $11.5 million the previous year. For 2021, guidance suggests revenue growth of 26% to 32%, assuming no significant COVID-19 resurgence. Cash stood at $34.4 million as of December 31, 2020.

Venus Concept (NASDAQ: VERO) announced the signing of Venus Williams as the brand ambassador for its Venus Bliss™ product line. CEO Dom Serafino expressed enthusiasm about this partnership, stating Williams represents the company's vision and values. Williams, a highly accomplished athlete and entrepreneur, has a positive public image that aligns with the brand. Venus Concept is a leader in medical aesthetic technology, offering a range of minimally invasive and non-invasive products across over 60 countries.

Venus Concept (NASDA: VERO) announced its participation in major investor conferences in March 2021. The Oppenheimer 31st Annual Healthcare Conference will take place virtually from March 16-18, with management presenting at 3:10 p.m. ET on March 17. They will also participate in the Maxim Emerging Growth Conference on March 17-18, featuring a panel discussion on March 17 at 2:00 p.m. ET. Audio webcasts of these presentations will be available on their investor relations website.

Venus Concept, a leading global medical aesthetic technology firm, announced its participation in the H.C. Wainwright Annual Global Life Sciences Conference on March 9-10, 2021. The company's management will present virtually, with the presentation available on-demand starting March 9 at 7:00 a.m. Eastern Time. The audio webcast can be accessed on the company’s investor relations website, and an archive will be available post-conference. Venus Concept operates in over 60 countries, offering a broad range of minimally invasive aesthetic technologies and hair restoration systems.

Venus Concept, a leader in medical aesthetic technology, announced its participation in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 17, 2021, at 10:00 a.m. Eastern Time.

The engagement will feature a virtual fireside chat, accessible via an audio webcast on the Company’s investor relations website. Post-event, an archive of the webcast will be available for replay. Venus Concept specializes in minimally invasive aesthetic technologies and has operations in over 60 countries.

Venus Concept (NASDAQ: VERO) announced that it will release its fourth quarter and fiscal year 2020 financial results after the market closes on March 29, 2021. Management will host a conference call at 5:00 PM ET on the same day to discuss these results, with a question-and-answer session to follow. Participants can join by dialing 877-407-2991 and using access code 13715787. A live webcast will also be available on their investor relations website, with a replay option for those unable to attend.

Venus Concept (NASDAQ: VERO) reported preliminary revenue for Q4 2020, expecting between $25.3M to $26.3M, a decrease of 21% to 24% from Q4 2019. For FY 2020, revenue is projected at $77.5M to $78.5M, declining 36% to 37% year-over-year. Despite challenges from COVID-19, the company anticipates FY 2021 revenue growth of 27% to 31%, estimating between $98M to $103M. The management highlighted a strengthened balance sheet with approximately $30 million in cash, following recent financing activities, which they believe positions the company for future growth.